SXI Life Sciences
7.288,53
PKT
+69,99
PKT
+0,97
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.04.15 | Roche overweight | JP Morgan Chase & Co. | |
10.04.15 | Roche kaufen | Independent Research GmbH | |
08.04.15 | Roche Neutral | UBS AG | |
08.04.15 | Novartis buy | UBS AG | |
07.04.15 | Roche Neutral | Citigroup Corp. | |
01.04.15 | Novartis Equal weight | Barclays Capital | |
01.04.15 | Roche overweight | Barclays Capital | |
31.03.15 | Roche Outperform | Credit Suisse Group | |
31.03.15 | Roche overweight | JP Morgan Chase & Co. | |
04.03.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.15 | Roche Outperform | BNP PARIBAS | |
04.03.15 | Novartis Outperform | BNP PARIBAS | |
03.03.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
03.03.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
02.03.15 | Novartis buy | UBS AG | |
23.02.15 | BB Biotech Verkaufen | Independent Research GmbH | |
23.02.15 | Roche Neutral | UBS AG | |
20.02.15 | Novartis buy | Jefferies & Company Inc. | |
20.02.15 | Roche buy | Jefferies & Company Inc. | |
12.02.15 | Roche overweight | Barclays Capital | |
09.02.15 | Novartis buy | Citigroup Corp. | |
09.02.15 | Roche Neutral | Citigroup Corp. | |
09.02.15 | Roche overweight | JP Morgan Chase & Co. | |
02.02.15 | Roche Hold | Kepler Cheuvreux | |
29.01.15 | Roche buy | Deutsche Bank AG | |
29.01.15 | Roche overweight | Morgan Stanley | |
28.01.15 | Novartis neutral | Morgan Stanley | |
28.01.15 | Novartis overweight | JP Morgan Chase & Co. | |
28.01.15 | Novartis Hold | Deutsche Bank AG | |
28.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.01.15 | Novartis Halten | Independent Research GmbH | |
26.01.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
26.01.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
23.01.15 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
23.01.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.01.15 | Roche Outperform | BNP PARIBAS | |
22.01.15 | Novartis Outperform | BNP PARIBAS | |
22.01.15 | Novartis buy | UBS AG | |
22.01.15 | Roche Neutral | UBS AG | |
21.01.15 | Novartis neutral | Morgan Stanley |